Cargando…

The influence of continuous renal replacement therapy on 1,3-β-d-glucan levels in critically ill patients: a single-center retrospective propensity score study

1,3-β-d-Glucan (BDG) is commonly used for diagnosing invasive fungal infections (IFIs). While exposure to cellulose-based hemodialyzers is known to cause false-positive BDG results, the impact of modern hemofilters used in continuous renal replacement therapy (CRRT) remains unclear. This retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabanilla, M. Gabriela, Briski, Matthew J., Bruss, Zachary, Saa, Lisa, Vasquez, Pamela C., Rodriguez, Chelsea N., Mitchell, Jessica A., Bernauer, Michael L., Argyropoulos, Christos P., Crandall, Cameron S., Teixeira, J. Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547441/ https://www.ncbi.nlm.nih.gov/pubmed/37781748 http://dx.doi.org/10.1080/0886022X.2023.2255680

Ejemplares similares

174. Impact of Ceftaroline Duration after Bacteremia Clearance When Used in Combination Therapy for Persistent or High-grade MRSA Bacteremia
por: Cabanilla, M Gabriela, et al.
Publicado: (2023)

Treatment refractory Stenotrophomonas maltophilia bacteraemia and pneumonia in a COVID-19-positive patient
por: Pek, Zachary, et al.
Publicado: (2021)

Association between mortality and replacement solution bicarbonate concentration in continuous renal replacement therapy: A propensity-matched cohort study
por: Kashani, Kianoush, et al.
Publicado: (2017)

Efficacy of renal replacement therapy in critically ill patients: a propensity analysis
por: Clec'h, Christophe, et al.
Publicado: (2012)

Under the Skin: A Case Series of Clostridium sordellii Necrotizing Soft Tissue Infections in Patients Who Inject Drugs
por: Milano, Victoria R, et al.
Publicado: (2023)

Expression, stability, and replacement of glucan-remodeling enzymes during developmental transitions in Saccharomyces cerevisiae
por: Rolli, Eleonora, et al.
Publicado: (2011)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Continuous Renal Replacement Therapy in Pediatric Severe Sepsis: A Propensity Score-Matched Prospective Multicenter Cohort Study in the PICU
por: Miao, Huijie, et al.
Publicado: (2019)

Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
por: O'Brien, Zachary, et al.
Publicado: (2022)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis
por: Oh, Hyung Jung, et al.
Publicado: (2014)

1298. Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy
por: Kline, Ellen G, et al.
Publicado: (2020)

β-Glucan and Parasites
por: Vetvicka, V., et al.
Publicado: (2018)

Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CSF-Differentiated Macrophages
por: Moerings, Bart G. J., et al.
Publicado: (2021)

Risk of Bleeding after Colorectal Endoscopic Resection in Patients with Continued Warfarin Use Compared to Heparin Replacement: A Propensity Score Matching Analysis
por: Inagaki, Katsuaki, et al.
Publicado: (2021)

Continuous Infusion of Piperacillin/Tazobactam in Septic Critically Ill Patients—A Multicenter Propensity Matched Analysis
por: Gonçalves-Pereira, João, et al.
Publicado: (2012)

Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism
por: Gentry, Matthew S, et al.
Publicado: (2009)

Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy
por: Godaly, Gabriela, et al.
Publicado: (2016)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Body temperature and infection in critically ill patients on continuous kidney replacement therapy
por: Challener, Douglas W., et al.
Publicado: (2023)

Evaluation of oat β-glucan-marine collagen peptide mixed gel and its application as the fat replacer in the sausage products
por: Fan, Rui, et al.
Publicado: (2020)

Effectiveness of Oat-Hull-Based Ingredient as Fat Replacer to Produce Low Fat Burger with High Beta-Glucans Content
por: Summo, Carmine, et al.
Publicado: (2020)

Antioxidant Activity of β-Glucan
por: Kofuji, Kyoko, et al.
Publicado: (2012)

β-glucans and cholesterol (Review)
por: Sima, Petr, et al.
Publicado: (2018)

Hypothermia related to continuous renal replacement therapy: incidence and associated factors
por: Morsch, Cássia Maria Frediani, et al.
Publicado: (2021)

925. Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV
por: Cinquegrani, Mark, et al.
Publicado: (2020)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

β-Glucan Synthase Gene Overexpression and β-Glucans Overproduction in Pleurotus ostreatus Using Promoter Swapping
por: Chai, Ran, et al.
Publicado: (2013)

Immune-enhancing effect of water-soluble beta-glucan derived from enzymatic hydrolysis of yeast glucan
por: Xin, Yingji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1m7416g6fass04108qrn7hgf0